ONTTF News and Press, Oxford Nanopore

2024-03-06 19:50:04 ET Oxford Nanopore Technologies plc (ONTTF) FY2023 Earnings Conference Call March 6 2024 7:00 AM ET Company Participants Gordon Sanghera - Chief Executive Officer Nick Keher - Chief Financial Officer Conference Call Participants Veroni...

2024-03-06 09:16:55 ET More on Oxford Nanopore Oxford Nanopore: Ultra-Long Reads In A Short-Term Slump Historical earnings data for Oxford Nanopore Financial information for Oxford Nanopore Read the full article on Seeking Alpha For further details se...

2024-01-17 21:22:40 ET Summary Shares of Oxford Nanopore declined by 33% after slower than expected growth in the second half of 2023. Positive outlook on the company, but profitability not expected until 2026. Challenging market with slow adoption of new technology, but new p...

2023-12-12 14:16:54 ET Summary Illumina's market cap has fallen 80% from its all-time highs in 2021, but the divestment of Grail could bring it back on track. Illumina's competitive advantage lies in its scalable DNA sequencing platform and highly integrated system, which makes it...

2023-09-10 03:52:50 ET Summary Pacific Biosciences has a leading position within the fast-growing long-read DNA sequencer market. Moreover, it is expanding its high-accuracy long-read portfolio to grab more market share from Illumina. My DCF model indicates significant upside pote...

2023-09-06 13:38:09 ET Oxford Nanopore Technologies plc (ONTTF) Q2 2023 Earnings Call Transcript September 06, 2023 07:00 AM ET Company Participants Gordon Sanghera - Chief Executive Officer Tim Cowper - Chief Financial Officer Conference Call Participants ...

2023-03-24 15:50:10 ET Summary Oxford Nanopore Technologies plc offers an attractive long-term growth outlook, with structural growth drivers revolving around the expanding DNA sequencing market. The short-term outlook appears to be volatile and softer, with a decline in COVID-19 ...

2023-03-21 14:57:04 ET Oxford Nanopore Technologies plc (ONTTF) Q4 2022 Earnings Conference Call March 21, 2023 08:00 AM ET Company Participants Gordon Sanghera - Chief Executive Officer Tim Cowper - Chief Financial Officer Conference Call Participants Ch...

2023-03-21 11:25:19 ET Oxford Nanopore press release ( OTCPK:ONTTF ): FY Revenue of £198.6M (+48.5% Y/Y). Cash, cash equivalents and other liquid investments of £558.0 million. For further details see: Oxford Nanopore reports FY results

Summary Singular Genomics Systems is a unique opportunity to invest in a commercially-viable startup at the forefront of a rapidly expanding field. The company has adequate funding to maintain its current level of commercialization and sales activity for a few years. Capital gains c...